Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_43236 | 107 | 2.24 | Mlig455_039667 | Neo: - Age: Down-Down-Up |
CAMKK2 | Mlig455_039667 {REF} {Length: 2203} {Pfam: Protein kinase domain [PF00069.27, score=200.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=113.0]; Kinase-like [PF14531.8, score=26.6]} {Human: ENSG00000110931, CAMKK2, calcium/calmodulin dependent protein kinase kinase 2, [Score=381, Expect=9e-125]; ENSG00000004660, CAMKK1, calcium/calmodulin dependent protein kinase kinase 1, [Score=364, Expect=2e-118]} {Mouse: ENSMUSG00000029471, Camkk2, calcium/calmodulin-dependent protein kinase kinase 2, beta, [Score=374, Expect=5e-122]; ENSMUSG00000020785, Camkk1, calcium/calmodulin-dependent protein kinase kinase 1, alpha, [Score=359, Expect=1e-116]} {Dmel: FBgn0040056, CG17698, [Score=358, Expect=2e-114]} {Celegans: WBGene00000518, ckk-1, Calcium/calmodulin-dependent protein kinase kinase, [Score=363, Expect=1e-119]} {Smed: dd_Smed_v6_18437_0_1, dd_Smed_v6_18437_0_1, [Score=338, Expect=9e-108]} {RNA1310_35311.1} {RNA815_49857} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.106 | 1.805 | 0.71150 | 1.00000 | |
RegionR2 | 1.642 | 1.805 | 0.20933 | 0.57264 | |
RegionR3 | -2.393 | 1.805 | 1.00000 | 1.00000 | |
RegionR4 | 1.038 | 1.805 | 0.40458 | 0.73147 | |
RegionR5 | -1.044 | 1.805 | 0.99052 | 1.00000 | |
RegionR6 | 0.453 | 1.805 | 0.66192 | 1.00000 | |
RegionR7 | 0.483 | 1.805 | 0.72385 | 1.00000 | |
RegionR8 | 1.927 | 1.805 | 0.30806 | 0.94024 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 5.522 | 1.805 | 0.28396 | 0.98366 | |
RegenerationR2 | 0.397 | 1.805 | 0.55883 | 0.89787 | |
RegenerationR3 | 2.072 | 1.805 | 0.09923 | 0.50262 | |
RegenerationR4 | -1.462 | 1.805 | 0.14186 | 0.56449 | |
RegenerationR5 | -0.113 | 1.805 | 0.93544 | 1.00000 | |
RegenerationR6 | -1.385 | 1.805 | 0.17524 | 0.50812 | |
RegenerationBL | -1.033 | 1.805 | 0.43323 | 0.80150 | |
RegenerationTP | -0.576 | 1.805 | 0.68267 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_43236 | 107 | 2.24 | Mlig455_039667 | Neo: - Age: Down-Down-Up |
CAMKK2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_039667 {REF} {Length: 2203} {Pfam: Protein kinase domain [PF00069.27, score=200.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=113.0]; Kinase-like [PF14531.8, score=26.6]} {Human: ENSG00000110931, CAMKK2, calcium/calmodulin dependent protein kinase kinase 2, [Score=381, Expect=9e-125]; ENSG00000004660, CAMKK1, calcium/calmodulin dependent protein kinase kinase 1, [Score=364, Expect=2e-118]} {Mouse: ENSMUSG00000029471, Camkk2, calcium/calmodulin-dependent protein kinase kinase 2, beta, [Score=374, Expect=5e-122]; ENSMUSG00000020785, Camkk1, calcium/calmodulin-dependent protein kinase kinase 1, alpha, [Score=359, Expect=1e-116]} {Dmel: FBgn0040056, CG17698, [Score=358, Expect=2e-114]} {Celegans: WBGene00000518, ckk-1, Calcium/calmodulin-dependent protein kinase kinase, [Score=363, Expect=1e-119]} {Smed: dd_Smed_v6_18437_0_1, dd_Smed_v6_18437_0_1, [Score=338, Expect=9e-108]} {RNA1310_35311.1} {RNA815_49857} |
2. | MligTC455_25056 | 93 | 1.94 | Mlig455_049698, Mlig455_049704 | Neo: - Age: - Region-enriched R2: 5.783/0.00015 |
3.306 | 0.780 | - | 0.841 | 0.957 | - | 0.728 | Mlig455_049698 {REF} {Length: 2094} {Smed: dd_Smed_v6_10049_0_1, dd_Smed_v6_10049_0_1, [Score=104, Expect=1e-23]} {RNA1310_40293} {RNA815_29568} Mlig455_049704 {REF} {Length: 2512} {RNA1509_20101} {RNA1310_40293} {RNA815_29568} |
|
3. | MligTC455_45719 | 94 | 1.96 | Mlig455_056535 | Neo: - Age: - |
CHRNA6 | 3.286 | 0.711 | - | 0.777 | 0.974 | 0.824 | - | Mlig455_056535 {REF} {Length: 2532} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=102.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=1e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=125, Expect=4e-31]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=125, Expect=5e-31]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=120, Expect=1e-29]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=117, Expect=4e-28]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=125, Expect=3e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=122, Expect=4e-30]} {RNA1509_7752} {RNA1310_37530} {RNA815_18433} |
4. | MligTC455_40782 | 1513 | 31.52 | Mlig455_021202 | Neo: - Age: Up-Down-Up Region-specific R2: 2.950 Region-enriched R2: 1.950/0.00004 Regeneration-downregulated BL: -2.428 Regeneration-depleted BL: -2.428 |
3.224 | - | - | 0.735 | 0.951 | 0.815 | 0.723 | Mlig455_021202 {REF} {Length: 2276} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} | |
5. | MligTC455_40334 | 37 | 0.77 | Mlig455_060664 | Neo: - Age: - |
2.799 | - | - | 0.868 | 0.950 | 0.981 | - | Mlig455_060664 {REF} {Length: 529} {RNA1509_15938} {RNA1310_60401} {RNA815_36308} | |
6. | MligTC455_19410 | 194 | 4.04 | Mlig455_047838 | Neo: - Age: Down-Up-Up Region-specific R2: 5.170 Region-enriched R2: 5.689/0.00000 |
2.751 | - | - | 0.881 | 0.959 | 0.911 | - | Mlig455_047838 {REF} {Length: 724} {TRANSSPLICED} {RNA1509_54915} {RNA1310_53549} {RNA815_27051} | |
7. | MligTC455_50171 | 151 | 3.14 | Mlig455_065462 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.212 Region-enriched R2: 5.063/0.00089 Regeneration-downregulated R2: -2.783 Regeneration-depleted R2: -2.783 |
SCNN1A | 2.712 | - | - | 0.836 | 0.970 | 0.906 | - | Mlig455_065462 {REF} {Length: 3905} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=67.0, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=92.8, Expect=1e-19]} {Smed: dd_Smed_v6_16959_0_1, dd_Smed_v6_16959_0_1, [Score=275, Expect=3e-83]} {RNA1509_60030} {RNA1310_56761} {RNA815_31877.1} |
8. | MligTC455_25602 | 236 | 4.91 | Mlig455_049410 | Neo: - Age: - |
2.658 | - | - | 0.776 | 0.897 | 0.985 | - | Mlig455_049410 {REF} {Length: 565} {RNA1509_38952} {RNA1310_62775} {RNA815_32364} | |
9. | MligTC455_39544 | 611 | 12.73 | Mlig455_001809, Mlig455_001836, Mlig455_062227, Mlig455_062236 | Neo: - Age: - Region-specific R2: 8.576 Region-enriched R2: 8.112/0.00016 |
2.646 | - | - | 0.769 | 0.898 | 0.979 | - | Mlig455_001809 {REF} {Length: 1067} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_001836 {REF} {Length: 1065} {RNA1509_52939} {RNA1310_72581, RNA1509_52939} {RNA1509_52939, RNA815_24546} Mlig455_062227 {REF} {Length: 3520} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_062236 {REF} {Length: 620} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} |
|
10. | MligTC455_41824 | 194 | 4.03 | Mlig455_048229 | Neo: - Age: - Region-enriched R2: 3.040/0.03860 |
2.643 | - | - | 0.898 | 0.965 | - | 0.780 | Mlig455_048229 {REF} {Length: 769} {RNA1509_49797} {RNA1310_60350, RNA1509_49797} {RNA1509_49797, RNA815_30999} | |
11. | MligTC455_22254 | 7695 | 160.31 | Mlig455_000728, Mlig455_000775 | Neo: - Age: - Region-specific R2: 6.574 Region-enriched R2: 5.474/0.00000 |
2.619 | - | - | 0.728 | 0.951 | 0.940 | - | Mlig455_000728 {REF} {Length: 129} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} Mlig455_000775 {REF} {Length: 126} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} |
|
12. | MligTC455_49073 | 824 | 17.17 | Mlig455_063174 | Neo: - Age: Down-Down-Up Region-specific R2: 4.151 Region-enriched R2: 3.105/0.00023 |
2.618 | - | - | 0.768 | 0.962 | 0.888 | - | Mlig455_063174 {REF} {Length: 1083} {RNA1509_9056} {RNA1310_56777} {RNA815_24608} | |
13. | MligTC455_49072 | 2077 | 43.26 | Mlig455_045808 | Neo: - Age: Down-Up-Up Region-specific R2: 2.466 Region-enriched R2: 1.923/0.00002 |
2.607 | - | - | 0.785 | 0.953 | 0.869 | - | Mlig455_045808 {REF} {Length: 1508} {RNA1509_9056} {RNA1310_56777} {RNA815_24608} | |
14. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
2.589 | - | - | 0.824 | 0.953 | - | 0.812 | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
15. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 2.588 | 0.717 | - | 0.912 | 0.959 | - | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
16. | MligTC455_31031 | 361 | 7.53 | Mlig455_009779 | Neo: - Age: - Region-enriched R2: 2.821/0.00350 |
LRRN3 | 2.57 | - | - | 0.810 | 0.954 | - | 0.806 | Mlig455_009779 {REF} {Length: 3647} {Pfam: Immunoglobulin domain [PF13927.8, score=35.5]; Immunoglobulin I-set domain [PF07679.18, score=34.5]; Immunoglobulin domain [PF00047.27, score=29.1]; Apolipoprotein A1/A4/E domain [PF01442.20, score=19.2]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [Score=56.2, Expect=2e-07]} {Dmel: FBgn0032479, CG16974, [RH, Score=116, Expect=3e-26]} {RNA1509_10344} {RNA1310_3046.1} {RNA815_12103} |
17. | MligTC455_41968 | 247 | 5.15 | Mlig455_048152 | Neo: - Age: - Region-specific R2: 5.996 Region-enriched R2: 5.206/0.00199 |
2.556 | - | - | 0.704 | 0.952 | 0.900 | - | Mlig455_048152 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.6]} {RNA1509_40628} {RNA1310_50753} {RNA815_21607} | |
18. | MligTC455_43543 | 254 | 5.28 | Mlig455_045209 | Neo: - Age: logFC(26M/2M)=-1.220 |
2.546 | - | - | 0.859 | 0.961 | 0.726 | - | Mlig455_045209 {REF} {Length: 1513} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=46.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=22.6]} {Smed: dd_Smed_v6_13661_0_1, dd_Smed_v6_13661_0_1, [Score=80.5, Expect=4e-17]} {RNA1509_44932} {RNA1310_25686, RNA1509_44932} {RNA1509_44932, RNA815_11495} | |
19. | MligTC455_19524 | 100 | 2.09 | Mlig455_010263 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.437/0.01311 |
2.543 | 0.712 | - | 0.872 | - | 0.959 | - | Mlig455_010263 {REF} {Length: 2969} {RNA1310_11925.1} {RNA815_27110} | |
20. | MligTC455_49099 | 448 | 9.33 | Mlig455_017685, Mlig455_017754, Mlig455_053758 | Neo: - Age: - Region-specific R2: 3.886 |
DAPK1 | 2.542 | - | - | - | 0.775 | 0.980 | 0.787 | Mlig455_017685 {REF} {Length: 4238} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=123.8]; Ankyrin repeats (many copies) [PF13857.8, score=98.6]; Ankyrin repeats (many copies) [PF13637.8, score=87.3]; Ankyrin repeat [PF00023.32, score=84.7]; Ankyrin repeat [PF13606.8, score=83.5]; Death domain [PF00531.24, score=51.6]; C-terminal of Roc, COR, domain [PF16095.7, score=29.6]} {Human: ENSG00000196730, DAPK1, death associated protein kinase 1, [RH, Score=496, Expect=6e-154]} {Mouse: ENSMUSG00000021559, Dapk1, death associated protein kinase 1, [RH, Score=486, Expect=2e-150]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=129, Expect=1e-29]} {Celegans: WBGene00003400, dapk-1, Death-associated protein kinase dapk-1, [RH, Score=485, Expect=1e-151]} {Smed: dd_Smed_v6_9475_0_1, dd_Smed_v6_9475_0_1, [RH, Score=903, Expect=0.0]} {RNA1509_33335} {RNA1310_2934} {RNA815_10357} Mlig455_017754 {REF} {Length: 4057} {Pfam: Death domain [PF00531.24, score=52.2]; Ankyrin repeats (3 copies) [PF12796.9, score=41.8]; Ankyrin repeats (many copies) [PF13857.8, score=37.8]; Ankyrin repeat [PF00023.32, score=37.4]; Ankyrin repeat [PF13606.8, score=35.8]; C-terminal of Roc, COR, domain [PF16095.7, score=31.3]; Ankyrin repeats (many copies) [PF13637.8, score=24.5]} {Human: ENSG00000196730, DAPK1, death associated protein kinase 1, [Score=388, Expect=4e-117]} {Mouse: ENSMUSG00000021559, Dapk1, death associated protein kinase 1, [Score=379, Expect=3e-114]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00003400, dapk-1, Death-associated protein kinase dapk-1, [Score=407, Expect=2e-127]} {Smed: dd_Smed_v6_9475_0_1, dd_Smed_v6_9475_0_1, [Score=771, Expect=0.0]} {RNA1509_33335} {RNA1310_2934} {RNA815_10357} Mlig455_053758 {REF} {Length: 4268} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=123.8]; Ankyrin repeats (many copies) [PF13857.8, score=98.6]; Ankyrin repeats (many copies) [PF13637.8, score=87.3]; Ankyrin repeat [PF00023.32, score=84.7]; Ankyrin repeat [PF13606.8, score=83.5]; Death domain [PF00531.24, score=51.6]; C-terminal of Roc, COR, domain [PF16095.7, score=29.6]} {Human: ENSG00000196730, DAPK1, death associated protein kinase 1, [RH, Score=496, Expect=6e-154]} {Mouse: ENSMUSG00000021559, Dapk1, death associated protein kinase 1, [RH, Score=486, Expect=2e-150]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=129, Expect=1e-29]} {Celegans: WBGene00003400, dapk-1, Death-associated protein kinase dapk-1, [RH, Score=485, Expect=1e-151]} {Smed: dd_Smed_v6_9475_0_1, dd_Smed_v6_9475_0_1, [RH, Score=903, Expect=0.0]} {RNA1509_33335} {RNA1310_2934, RNA1509_33335} {RNA1509_33335, RNA815_10357} |
21. | MligTC455_36372 | 925 | 19.28 | Mlig455_005680 | Neo: - Age: logFC(26M/2M)=2.101 Region-enriched R2: 7.233/0.00006 |
2.472 | 0.711 | - | 0.809 | 0.952 | - | - | Mlig455_005680 {REF} {Length: 1993} {RNA1509_18409, RNA1509_31432} {RNA1310_82233, RNA1509_18409, RNA1509_31432} {RNA1509_18409, RNA1509_31432, RNA815_42934} | |
22. | MligTC455_44354 | 1240 | 25.82 | Mlig455_001577 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.349 Region-specific R2: 5.143 Region-enriched R2: 4.498/0.00000 Regeneration-downregulated R2: -2.807 Regeneration-depleted R2: -2.807 |
2.444 | - | - | 0.771 | 0.957 | 0.716 | - | Mlig455_001577 {REF} {Length: 1028} {RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1310_49541.2, RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1509_23470, RNA1509_33941, RNA1509_57202, RNA815_59782} | |
23. | MligTC455_41174 | 229 | 4.78 | Mlig455_065231 | Neo: - Age: - Region-enriched R2: 3.572/0.04561 |
2.422 | - | - | 0.704 | 0.972 | 0.746 | - | Mlig455_065231 {REF} {Length: 1217} {Smed: dd_Smed_v6_20909_0_1, dd_Smed_v6_20909_0_1, [RH, Score=89.7, Expect=3e-21]} {RNA1310_30649} {RNA815_19980} | |
24. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.417 | 0.702 | - | 0.756 | 0.959 | - | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
25. | MligTC455_24272 | 197 | 4.1 | Mlig455_005121, Mlig455_005189 | Neo: - Age: Down-Up-Down |
CHRNA7 | 1.926 | - | - | - | 0.937 | 0.989 | - | Mlig455_005121 {REF} {Length: 1737} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=104.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=68.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=135, Expect=4e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=134, Expect=3e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=134, Expect=3e-34]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=131, Expect=3e-33]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=127, Expect=5e-32]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=119, Expect=6e-29]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=129, Expect=1e-32]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=120, Expect=2e-29]} {RNA1509_43533} {RNA1310_19997.1, RNA1509_43533} {RNA1509_43533, RNA815_7971} Mlig455_005189 {REF} {Length: 1477} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=68.4]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=2e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=1e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=2e-34]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=133, Expect=8e-34]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=128, Expect=4e-32]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=117, Expect=4e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=130, Expect=1e-32]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=117, Expect=3e-28]} {RNA1509_43533} {RNA1310_19997.1} {RNA815_7971} |
26. | MligTC455_20013 | 777 | 16.18 | Mlig455_002334, Mlig455_002335, Mlig455_019758 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.606/0.00058 |
STOM | 1.924 | - | - | - | 0.945 | 0.979 | - | Mlig455_002334 {REF} {Length: 2498} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=113.3]} {Human: ENSG00000148175, STOM, stomatin, [Score=290, Expect=1e-95]; ENSG00000133115, STOML3, stomatin like 3, [Score=290, Expect=8e-96]} {Mouse: ENSMUSG00000027744, Stoml3, stomatin (Epb7.2)-like 3, [Score=288, Expect=6e-95]; ENSMUSG00000026880, Stom, stomatin, [Score=286, Expect=3e-94]} {Dmel: FBgn0260657, CG42540, [Score=301, Expect=9e-99]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [Score=305, Expect=1e-100]} {Smed: dd_Smed_v6_16206_0_1, dd_Smed_v6_16206_0_1, [RH, Score=376, Expect=2e-129]} {RNA1509_30153, RNA1509_46680} {RNA1310_12353, RNA1509_30153, RNA1509_46680} {RNA1509_30153, RNA1509_46680, RNA815_4616.1} Mlig455_002335 {REF} {Length: 1313} {NoTransDecoderORF} {RNA1509_20999} {RNA1310_66086} {RNA815_7817} Mlig455_019758 {REF} {Length: 2302} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=113.0]} {Human: ENSG00000148175, STOM, stomatin, [Score=290, Expect=9e-96]; ENSG00000133115, STOML3, stomatin like 3, [Score=290, Expect=8e-96]} {Mouse: ENSMUSG00000027744, Stoml3, stomatin (Epb7.2)-like 3, [Score=287, Expect=7e-95]; ENSMUSG00000026880, Stom, stomatin, [Score=286, Expect=3e-94]} {Dmel: FBgn0260657, CG42540, [Score=301, Expect=9e-99]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [Score=305, Expect=1e-100]} {Smed: dd_Smed_v6_16206_0_1, dd_Smed_v6_16206_0_1, [RH, Score=377, Expect=5e-130]} {RNA1509_30153} {RNA1310_12353} {RNA815_4616.1} |
27. | MligTC455_26690 | 58 | 1.2 | Mlig455_044790 | Neo: - Age: - |
PDE9A | 1.918 | - | - | - | 0.970 | 0.948 | - | Mlig455_044790 {REF} {Length: 2883} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=286.3]} {Human: ENSG00000160191, PDE9A, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Mouse: ENSMUSG00000041119, Pde9a, phosphodiesterase 9A, [RH, Score=605, Expect=0.0]} {Dmel: FBgn0259171, Pde9, Phosphodiesterase 9, [RH, Score=353, Expect=3e-108]} {Celegans: WBGene00020114, pde-4, Probable 3',5'-cyclic phosphodiesterase pde-4, [Score=186, Expect=5e-52]} {Smed: dd_Smed_v6_13304_0_1, dd_Smed_v6_13304_0_1, [RH, Score=328, Expect=6e-106]} {RNA1310_14017} {RNA815_23817} |
28. | MligTC455_17802 | 4269 | 88.94 | Mlig455_014107, Mlig455_014119 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.293 Region-enriched R2: 4.660/0.00000 |
1.903 | - | - | - | 0.961 | 0.942 | - | Mlig455_014107 {REF} {Length: 768} {RNA1509_50290, RNA1509_8001} {RNA1310_50688, RNA1509_50290, RNA1509_8001} {RNA1509_50290, RNA1509_8001, RNA815_23571} Mlig455_014119 {REF} {Length: 789} {RNA1509_50290} {RNA1310_50688} {RNA815_23571} |
|
29. | MligTC455_42313 | 496 | 10.33 | Mlig455_047802 | Neo: - Age: Down-Up-Up Region-specific R2: 5.966 Region-enriched R2: 4.823/0.00000 Regeneration-downregulated R2: -2.674 Regeneration-depleted R2: -2.674 |
1.903 | - | - | - | 0.953 | 0.950 | - | Mlig455_047802 {REF} {Length: 1225} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=21.5]} {RNA1509_51722} {RNA1310_51935, RNA1509_51722} {RNA1509_51722, RNA815_15783.2} | |
30. | MligTC455_51009 | 16 | 0.33 | Mlig455_057754 | Neo: - Age: - |
1.902 | - | - | 0.953 | 0.949 | - | - | Mlig455_057754 {REF} {Length: 198} {NoTransDecoderORF} | |
31. | MligTC455_17803 | 2158 | 44.95 | Mlig455_014128 | Neo: - Age: - Region-specific R2: 5.111 Region-enriched R2: 4.751/0.00000 |
1.899 | - | - | - | 0.960 | 0.939 | - | Mlig455_014128 {REF} {Length: 974} {RNA1509_50290} {RNA1310_50688} {RNA815_23571} | |
32. | MligTC455_25766 | 42 | 0.88 | Mlig455_008785, Mlig455_008821, Mlig455_008919 | Neo: - Age: - Region-enriched R2: 5.588/0.00166 |
1.896 | - | - | 0.919 | 0.977 | - | - | Mlig455_008785 {REF} {Length: 1744} {RNA1310_20437} {RNA815_15201} Mlig455_008821 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} Mlig455_008919 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} |
|
33. | MligTC455_44340 | 133 | 2.77 | Mlig455_046547 | Neo: - Age: Up-Down-Down |
GPR158 | 1.888 | - | - | - | 0.956 | 0.932 | - | Mlig455_046547 {REF} {Length: 3465} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=94.2]} {Human: ENSG00000151025, GPR158, G protein-coupled receptor 158, [RH, Score=246, Expect=8e-68]; ENSG00000276469, GPR179, G protein-coupled receptor 179, [RH, Score=240, Expect=3e-65]; ENSG00000277399, GPR179, G protein-coupled receptor 179, [RH, Score=234, Expect=3e-63]} {Mouse: ENSMUSG00000070337, Gpr179, G protein-coupled receptor 179, [RH, Score=253, Expect=7e-70]; ENSMUSG00000045967, Gpr158, G protein-coupled receptor 158, [RH, Score=251, Expect=1e-69]} {Dmel: FBgn0051660, smog, [RH, Score=285, Expect=1e-82]} {Celegans: WBGene00009558, F39B2.8, [Score=195, Expect=3e-53]} {Smed: dd_Smed_v6_8408_0_1, dd_Smed_v6_8408_0_1, [RH, Score=356, Expect=2e-111]} {RNA1509_37699} {RNA1310_6430, RNA1509_37699} {RNA1509_37699, RNA815_19661} |
34. | MligTC455_40269 | 12 | 0.24 | Mlig455_034132 | Neo: - Age: - |
PRKAR1B | 1.879 | - | - | 0.894 | 0.985 | - | - | Mlig455_034132 {REF} {Length: 1982} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=71.9]} {Human: ENSG00000188191, PRKAR1B, protein kinase cAMP-dependent type I regulatory subunit beta, [Score=51.6, Expect=5e-07]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=47.4, Expect=1e-05]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=54.3, Expect=3e-08]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=99.0, Expect=3e-23]} {RNA1509_58940} {RNA1310_17699} {RNA815_19132} |
35. | MligTC455_15765 | 194 | 4.05 | Mlig455_007606 | Neo: - Age: - |
1.875 | - | - | - | 0.883 | 0.992 | - | Mlig455_007606 {REF} {Length: 1349} {RNA1310_25770.1} {RNA815_11095} | |
36. | MligTC455_53239 | 733 | 15.27 | Mlig455_025537 | Neo: - Age: - Region-specific R2: 4.434 Region-enriched R2: 3.108/0.00000 |
1.873 | - | - | - | 0.901 | 0.972 | - | Mlig455_025537 {REF} {Length: 964} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=70.9, Expect=5e-15]} {Celegans: WBGene00010290, F58H1.7, [Score=63.9, Expect=8e-13]} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [RH, Score=168, Expect=2e-53]} {RNA1509_58542} {RNA1310_40950} {RNA815_19778.1} | |
37. | MligTC455_08591 | 42 | 0.87 | Mlig455_020619 | Neo: - Age: - |
PHOX2B | 1.869 | - | - | 0.907 | 0.962 | - | - | Mlig455_020619 {REF} {Length: 1413} {Pfam: Homeodomain [PF00046.31, score=80.5]} {Human: ENSG00000109132, PHOX2B, paired like homeobox 2B, [RH, Score=135, Expect=3e-36]; ENSG00000165462, PHOX2A, paired like homeobox 2A, [RH, Score=129, Expect=2e-34]} {Mouse: ENSMUSG00000012520, Phox2b, paired-like homeobox 2b, [RH, Score=135, Expect=2e-36]; ENSMUSG00000007946, Phox2a, paired-like homeobox 2a, [RH, Score=129, Expect=1e-34]} {Dmel: FBgn0025334, PHDP, Putative homeodomain protein, [RH, Score=119, Expect=2e-31]} {Celegans: WBGene00000440, ceh-17, C. Elegans Homeobox; CEH-17, [RH, Score=132, Expect=2e-36]} {Smed: dd_Smed_v6_29211_0_1, dd_Smed_v6_29211_0_1, [RH, Score=146, Expect=2e-40]} {RNA1310_111052} |
38. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 1.868 | - | - | 0.886 | 0.982 | - | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
39. | MligTC455_17565 | 85 | 1.77 | Mlig455_054318 | Neo: - Age: - Region-enriched R2: 6.111/0.00708 |
1.858 | - | - | 0.892 | 0.966 | - | - | Mlig455_054318 {REF} {Length: 550} {RNA1310_73705} {RNA815_38857} | |
40. | MligTC455_39821 | 45 | 0.94 | Mlig455_020248 | Neo: - Age: - |
DRGX | 1.851 | - | - | 0.875 | - | 0.976 | - | Mlig455_020248 {REF} {Length: 1773} {Pfam: Homeodomain [PF00046.31, score=83.1]} {Human: ENSG00000165606, DRGX, dorsal root ganglia homeobox, [RH, Score=132, Expect=4e-35]} {Mouse: ENSMUSG00000041730, Prrxl1, paired related homeobox protein-like 1, [RH, Score=133, Expect=1e-35]} {Dmel: FBgn0085369, Drgx, Dorsal root ganglia homeobox, [RH, Score=152, Expect=3e-40]} {Celegans: WBGene00000440, ceh-17, C. Elegans Homeobox; CEH-17, [Score=112, Expect=3e-28]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [RH, Score=159, Expect=2e-47]} {RNA1310_82891} |
41. | MligTC455_40779 | 191 | 3.98 | Mlig455_000277, Mlig455_035731, Mlig455_058356 | Neo: - Age: - Region-enriched R4: 3.665/0.04268 |
1.85 | - | - | 0.896 | 0.954 | - | - | Mlig455_000277 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_035731 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_058356 {REF} {Length: 1050} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} |
|
42. | MligTC455_11160 | 13 | 0.28 | Mlig455_053261, Mlig455_065033 | Neo: - Age: - |
1.843 | - | - | 0.870 | 0.973 | - | - | Mlig455_053261 {REF} {Length: 1117} Mlig455_065033 {REF} {Length: 776} |
|
43. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
1.84 | - | - | 0.884 | 0.956 | - | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
44. | MligTC455_41195 | 25 | 0.53 | Mlig455_017236 | Neo: - Age: - |
1.839 | - | - | 0.878 | 0.961 | - | - | Mlig455_017236 {REF} {Length: 591} {NoTransDecoderORF} {RNA1310_58555} {RNA815_29982} | |
45. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 1.836 | - | - | 0.885 | 0.951 | - | - | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
46. | MligTC455_25556 | 160 | 3.33 | Mlig455_041382 | Neo: - Age: - Region-specific R2: 5.503 Region-enriched R2: 4.706/0.00082 |
1.831 | - | - | 0.873 | 0.958 | - | - | Mlig455_041382 {REF} {Length: 1197} {RNA1509_55439} {RNA1310_65119, RNA1509_55439} {RNA1509_55439, RNA815_36098.2} | |
47. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 1.828 | - | - | 0.877 | 0.951 | - | - | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
48. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 1.826 | - | - | 0.858 | 0.968 | - | - | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
49. | MligTC455_24949 | 24 | 0.51 | Mlig455_053970 | Neo: - Age: Up-Down-Down |
AHNAK | 1.825 | - | - | 0.856 | - | 0.969 | - | Mlig455_053970 {REF} {Length: 8177} {Pfam: Herpes virus major outer envelope glycoprotein (BLLF1) [PF05109.15, score=19.9]} {Human: ENSG00000124942, AHNAK, AHNAK nucleoprotein, [Score=142, Expect=9e-33]} {Mouse: ENSMUSG00000069833, Ahnak, AHNAK nucleoprotein (desmoyokin), [Score=136, Expect=3e-31]} {Dmel: FBgn0259108, futsch, [Score=57.0, Expect=3e-07]} {Smed: dd_Smed_v6_9830_0_1, dd_Smed_v6_9830_0_1, [Score=52.0, Expect=3e-06]} {RNA1509_39227} {RNA1310_19750.1} {RNA815_47018} |
50. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 1.807 | - | - | 0.852 | 0.955 | - | - | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
51. | MligTC455_28903 | 55 | 1.14 | Mlig455_030222, Mlig455_067999 | Neo: - Age: Up-Down-Down |
FAT4 | 1.801 | - | - | 0.847 | 0.954 | - | - | Mlig455_030222 {REF} {Length: 8676} {Pfam: Cadherin domain [PF00028.19, score=744.0]; Cadherin-like [PF16184.7, score=94.9]; Cadherin-like [PF08266.14, score=40.7]; RET Cadherin like domain 1 [PF17756.3, score=23.4]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=518, Expect=1e-147]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=9e-152]} {Dmel: FBgn0001075, ft, fat, [Score=479, Expect=9e-136]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=260, Expect=4e-69]} {RNA1509_58830} {RNA1310_15141, RNA1509_58830} {RNA1509_58830, RNA815_18357} Mlig455_067999 {REF} {Length: 8147} {Pfam: Cadherin domain [PF00028.19, score=745.9]; Cadherin-like [PF16184.7, score=94.8]; Cadherin-like [PF08266.14, score=40.9]; RET Cadherin like domain 1 [PF17756.3, score=23.3]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=519, Expect=6e-148]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=7e-152]} {Dmel: FBgn0001075, ft, fat, [Score=476, Expect=8e-135]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=261, Expect=2e-69]} {RNA1509_58830} {RNA1310_15141} {RNA815_18357} |
52. | MligTC455_23716 | 142 | 2.96 | Mlig455_046798 | Neo: - Age: Down-Down-Down |
1.798 | - | - | 0.829 | 0.969 | - | - | Mlig455_046798 {REF} {Length: 1088} {RNA1509_35160} {RNA1310_48019} {RNA815_16808} | |
53. | MligTC455_20335 | 30 | 0.62 | Mlig455_003579 | Neo: - Age: - |
1.795 | - | - | - | 0.829 | 0.966 | - | Mlig455_003579 {REF} {Length: 3608} {RNA1310_50785} {RNA815_44116} | |
54. | MligTC455_15182 | 24 | 0.49 | Mlig455_008075 | Neo: - Age: - |
1.793 | - | - | 0.832 | 0.961 | - | - | Mlig455_008075 {REF} {Length: 1623} {RNA1310_145272} | |
55. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 1.793 | - | - | - | 0.963 | 0.830 | - | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
56. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
1.793 | - | - | 0.830 | 0.963 | - | - | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
57. | MligTC455_45314 | 24 | 0.5 | Mlig455_043345 | Neo: - Age: - |
1.791 | - | - | 0.831 | 0.960 | - | - | Mlig455_043345 {REF} {Length: 1422} {Pfam: Pancreatic hormone peptide [PF00159.20, score=27.9]} {RNA1310_91502} {RNA815_61453} | |
58. | MligTC455_46173 | 63 | 1.3 | Mlig455_032091 | Neo: Irradiation Age: Up-Down-Up |
SRR | 1.788 | - | - | 0.954 | 0.834 | - | - | Mlig455_032091 {REF} {Length: 2590} {Pfam: Pyridoxal-phosphate dependent enzyme [PF00291.27, score=208.5]; ACT domain [PF01842.27, score=19.8]} {Human: ENSG00000167720, SRR, serine racemase, [Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000001323, Srr, serine racemase, [Score=105, Expect=4e-24]} {Dmel: FBgn0037684, CG8129, [Score=373, Expect=5e-123]} {Celegans: WBGene00010456, K01C8.1, [Score=407, Expect=5e-136]} {Smed: dd_Smed_v6_6737_0_1, dd_Smed_v6_6737_0_1, [Score=474, Expect=7e-163]} {RNA1509_48789} {RNA1310_15074} {RNA815_9364} |
59. | MligTC455_08985 | 113 | 2.35 | Mlig455_040705, Mlig455_064574 | Neo: - Age: - Region-enriched R2: 4.395/0.00815 |
1.787 | - | - | 0.833 | 0.954 | - | - | Mlig455_040705 {REF} {Length: 2178} {NoTransDecoderORF} {RNA1509_57682} {RNA1310_91022} {RNA815_41716} Mlig455_064574 {REF} {Length: 4370} {Celegans: WBGene00006349, sur-2, Mediator of RNA polymerase II transcription subunit 23, [Score=48.5, Expect=1e-05]} {RNA1509_57682} {RNA1310_44678, RNA1509_57682} {RNA1509_57682, RNA815_41716} |
|
60. | MligTC455_18505 | 15 | 0.31 | Mlig455_017536 | Neo: - Age: - |
1.786 | - | - | 0.831 | 0.955 | - | - | Mlig455_017536 {REF} {Length: 2174} {RNA1310_61282} {RNA815_41334} | |
61. | MligTC455_14752 | 17 | 0.36 | Mlig455_009102 | Neo: - Age: - |
1.779 | - | - | 0.816 | 0.963 | - | - | Mlig455_009102 {REF} {Length: 1690} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=89.7, Expect=1e-19]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
62. | MligTC455_46004 | 40 | 0.83 | Mlig455_053399 | Neo: - Age: - |
1.773 | - | - | 0.811 | 0.962 | - | - | Mlig455_053399 {REF} {Length: 583} {NoTransDecoderORF} {RNA1310_66147} {RNA815_35487} | |
63. | MligTC455_19449 | 235 | 4.9 | Mlig455_048896 | Neo: - Age: logFC(26M/2M)=-0.470 Region-enriched R2: 3.185/0.00006 |
1.77 | - | - | 0.818 | 0.952 | - | - | Mlig455_048896 {REF} {Length: 1819} {Pfam: Innexin [PF00876.20, score=25.6]} {RNA1509_47060} {RNA1310_19756.1, RNA1509_47060} {RNA1509_47060, RNA815_16217} | |
64. | MligTC455_39396 | 469 | 9.77 | Mlig455_031203 | Neo: - Age: - Region-enriched R8: 3.069/0.00001 |
ARRDC3 | 1.767 | - | - | - | 0.794 | 0.973 | - | Mlig455_031203 {REF} {Length: 1835} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=114.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=66.5]; Rgp1 [PF08737.12, score=23.6]} {Human: ENSG00000113369, ARRDC3, arrestin domain containing 3, [Score=112, Expect=5e-27]} {Mouse: ENSMUSG00000074794, Arrdc3, arrestin domain containing 3, [Score=113, Expect=1e-27]} {Dmel: FBgn0037517, CG10086, [RH, Score=85.1, Expect=1e-17]} {Celegans: WBGene00009579, arrd-6, ARRestin Domain protein, [RH, Score=322, Expect=2e-106]} {RNA1509_30037} {RNA1310_19411, RNA1509_30037} {RNA1509_30037, RNA815_7851} |
65. | MligTC455_36944 | 22 | 0.45 | Mlig455_065298, Mlig455_065320 | Neo: - Age: Up-Down-Up |
NR2F1 | 1.766 | - | - | - | 0.962 | - | 0.804 | Mlig455_065298 {REF} {Length: 2485} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=100.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=95.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [RH, Score=241, Expect=4e-73]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [RH, Score=240, Expect=2e-72]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [RH, Score=240, Expect=1e-72]} {Dmel: FBgn0003651, svp, seven up, [RH, Score=240, Expect=3e-71]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [RH, Score=150, Expect=4e-40]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [RH, Score=211, Expect=4e-61]} Mlig455_065320 {REF} {Length: 3080} {Pfam: Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=76.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=215, Expect=6e-67]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [Score=214, Expect=5e-66]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=215, Expect=2e-68]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=214, Expect=4e-66]} {Dmel: FBgn0003651, svp, seven up, [Score=211, Expect=2e-66]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [Score=69.3, Expect=4e-13]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [Score=183, Expect=9e-54]} |
66. | MligTC455_45998 | 1124 | 23.42 | Mlig455_004117, Mlig455_060440 | Neo: - Age: - |
GNAO1 | 1.764 | - | - | - | 0.799 | 0.965 | - | Mlig455_004117 {REF} {Length: 3586} {Pfam: G-protein alpha subunit [PF00503.22, score=408.5]; ADP-ribosylation factor family [PF00025.23, score=62.4]; Gtr1/RagA G protein conserved region [PF04670.14, score=24.2]} {Human: ENSG00000087258, GNAO1, G protein subunit alpha o1, [RH, Score=617, Expect=0.0]} {Mouse: ENSMUSG00000031748, Gnao1, guanine nucleotide binding protein, alpha O, [RH, Score=614, Expect=0.0]} {Dmel: FBgn0001122, Galphao, G protein alpha o subunit, [RH, Score=649, Expect=0.0]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [RH, Score=643, Expect=0.0]} {Smed: dd_Smed_v6_1656_0_1, dd_Smed_v6_1656_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_41742, RNA1509_7653} {RNA1310_5003, RNA1509_41742, RNA1509_7653} {RNA1509_41742, RNA1509_7653, RNA815_2342} Mlig455_060440 {REF} {Length: 3397} {Pfam: G-protein alpha subunit [PF00503.22, score=408.5]; ADP-ribosylation factor family [PF00025.23, score=62.4]; Gtr1/RagA G protein conserved region [PF04670.14, score=24.2]} {Human: ENSG00000087258, GNAO1, G protein subunit alpha o1, [RH, Score=617, Expect=0.0]} {Mouse: ENSMUSG00000031748, Gnao1, guanine nucleotide binding protein, alpha O, [RH, Score=614, Expect=0.0]} {Dmel: FBgn0001122, Galphao, G protein alpha o subunit, [RH, Score=649, Expect=0.0]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [RH, Score=643, Expect=0.0]} {Smed: dd_Smed_v6_1656_0_1, dd_Smed_v6_1656_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_7653} {RNA1310_5003} {RNA815_2342} |
67. | MligTC455_32392 | 63 | 1.31 | Mlig455_048146 | Neo: - Age: - |
SDCBP2 | 1.762 | - | - | 0.796 | 0.966 | - | - | Mlig455_048146 {REF} {Length: 895} {Pfam: PDZ domain [PF00595.26, score=47.3]; PDZ domain [PF17820.3, score=35.5]; PDZ domain [PF13180.8, score=31.4]} {Human: ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=60.1, Expect=1e-10]} {Mouse: ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=61.2, Expect=3e-11]} {Dmel: FBgn0263289, scrib, scribbled, [Score=46.6, Expect=4e-06]} {Celegans: WBGene00016678, C45G9.7, [Score=44.3, Expect=4e-06]} {Smed: dd_Smed_v6_11951_0_1, dd_Smed_v6_11951_0_1, [Score=90.5, Expect=1e-21]} {RNA1310_28491} {RNA815_52955} |
68. | MligTC455_43116 | 105 | 2.2 | Mlig455_006245, Mlig455_006299, Mlig455_061192 | Neo: - Age: - |
ESRRB | 1.761 | - | - | 0.811 | 0.950 | - | - | Mlig455_006245 {REF} {Length: 450} {NoTransDecoderORF} Mlig455_006299 {REF} {Length: 2539} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.3]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=20.3]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=94.4, Expect=2e-20]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=88.2, Expect=1e-18]; ENSMUSG00000024955, Esrra, estrogen related receptor, alpha, [Score=86.7, Expect=3e-18]; ENSMUSG00000015846, Rxra, retinoid X receptor alpha, [Score=85.1, Expect=1e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=84.7, Expect=2e-17]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.9, Expect=3e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_3012_0_1, dd_Smed_v6_3012_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_86523} Mlig455_061192 {REF} {Length: 2120} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.2]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=19.6]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=97.4, Expect=2e-21]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=94.4, Expect=1e-20]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.1, Expect=4e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_13691_0_1, dd_Smed_v6_13691_0_1, [Score=79.7, Expect=1e-16]} {RNA1310_86523} |
69. | MligTC455_12388 | 25 | 0.52 | Mlig455_000936 | Neo: - Age: - |
SETMAR | 1.755 | - | - | 0.782 | 0.973 | - | - | Mlig455_000936 {REF} {Length: 2242} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=48.4]; DDE superfamily endonuclease [PF13358.8, score=29.0]; Homeodomain-like domain [PF13565.8, score=24.2]; Transposase [PF01498.20, score=21.1]; Winged helix-turn helix [PF13551.8, score=19.9]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=167, Expect=3e-45]} {Smed: dd_Smed_v6_52102_0_1, dd_Smed_v6_52102_0_1, [Score=69.7, Expect=1e-14]} {RNA1310_28836.1} {RNA815_34045} |
70. | MligTC455_26709 | 16729 | 348.53 | Mlig455_000778 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.490 Region-enriched R2: 4.780/0.00000 |
1.755 | - | - | - | 0.788 | 0.967 | - | Mlig455_000778 {REF} {Length: 348} {RNA1509_1140, RNA1509_2520} {RNA1310_112043, RNA1509_1140} {RNA1509_1140, RNA815_7257.7} | |
71. | MligTC455_51653 | 188 | 3.92 | Mlig455_026873, Mlig455_030823, Mlig455_047794 | Neo: - Age: Down-Up-Down |
DNASE1L1 | 1.755 | 0.780 | - | - | 0.975 | - | - | Mlig455_026873 {REF} {Length: 2133} {Pfam: Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=36.6]} {Human: ENSG00000013563, DNASE1L1, deoxyribonuclease 1 like 1, [RH, Score=167, Expect=5e-49]} {Mouse: ENSMUSG00000024136, Dnase1l2, deoxyribonuclease 1-like 2, [RH, Score=171, Expect=4e-51]} {RNA1310_32296.1} {RNA815_27566} Mlig455_030823 {REF} {Length: 2074} {Pfam: Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=37.1]} {Human: ENSG00000013563, DNASE1L1, deoxyribonuclease 1 like 1, [RH, Score=167, Expect=2e-49]} {Mouse: ENSMUSG00000024136, Dnase1l2, deoxyribonuclease 1-like 2, [RH, Score=171, Expect=1e-51]} {RNA1310_32296.2} {RNA815_27566} Mlig455_047794 {REF} {Length: 1791} {Pfam: Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=35.6]} {Human: ENSG00000013563, DNASE1L1, deoxyribonuclease 1 like 1, [RH, Score=166, Expect=2e-48]} {Mouse: ENSMUSG00000024136, Dnase1l2, deoxyribonuclease 1-like 2, [RH, Score=171, Expect=3e-51]} {RNA1310_32296.2} {RNA815_27566} |
72. | MligTC455_23718 | 156 | 3.25 | Mlig455_069946 | Neo: - |
1.754 | - | - | 0.792 | 0.962 | - | - | Mlig455_069946 {REF} {Length: 894} {RNA1509_35160} {RNA1310_48019} {RNA815_16808} | |
73. | MligTC455_46155 | 116 | 2.42 | Mlig455_027239 | Neo: - Age: - Region-enriched R2: 4.163/0.03818 |
GRK3 | 1.747 | - | - | 0.770 | 0.977 | - | - | Mlig455_027239 {REF} {Length: 2919} {Pfam: Protein kinase domain [PF00069.27, score=226.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=100.5]; Regulator of G protein signaling domain [PF00615.21, score=48.3]} {Human: ENSG00000100077, GRK3, G protein-coupled receptor kinase 3, [Score=845, Expect=0.0]; ENSG00000173020, GRK2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Mouse: ENSMUSG00000042249, Grk3, G protein-coupled receptor kinase 3, [Score=838, Expect=0.0]; ENSMUSG00000024858, Grk2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Dmel: FBgn0260798, Gprk1, G protein-coupled receptor kinase 1, [Score=842, Expect=0.0]} {Celegans: WBGene00001709, grk-2, G protein-coupled receptor kinase 2, [Score=819, Expect=0.0]} {Smed: dd_Smed_v6_6480_0_1, dd_Smed_v6_6480_0_1, [Score=949, Expect=0.0]} {RNA1509_7002} {RNA1310_16658} {RNA815_28070} |
74. | MligTC455_38698 | 945 | 19.68 | Mlig455_009780 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.658 Region-enriched R2: 1.739/0.00137 Regeneration-downregulated BL: -2.534 Regeneration-depleted BL: -2.534 |
COLEC10 | 1.738 | - | - | 0.765 | 0.973 | - | - | Mlig455_009780 {REF} {Length: 1506} {Pfam: Lectin C-type domain [PF00059.23, score=43.5]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
75. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 1.737 | - | - | 0.786 | 0.951 | - | - | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
76. | MligTC455_52480 | 25 | 0.51 | Mlig455_040937 | Neo: - Age: - |
1.734 | - | - | 0.777 | 0.957 | - | - | Mlig455_040937 {REF} {Length: 2050} {RNA1310_86606} {RNA815_50003.1} | |
77. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
1.729 | - | - | 0.769 | 0.960 | - | - | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
78. | MligTC455_10602 | 7 | 0.14 | Mlig455_069165 | Neo: - Age: - |
1.727 | - | - | 0.753 | 0.974 | - | - | Mlig455_069165 {REF} {Length: 609} | |
79. | MligTC455_31695 | 158 | 3.3 | Mlig455_009775 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.086/0.01194 |
1.719 | - | - | 0.743 | 0.976 | - | - | Mlig455_009775 {REF} {Length: 2186} {RNA1310_24838} {RNA815_18727} | |
80. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 1.718 | - | - | - | 0.960 | 0.758 | - | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
81. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
1.712 | - | - | 0.759 | 0.953 | - | - | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
82. | MligTC455_25313 | 529 | 11.03 | Mlig455_047806, Mlig455_047883 | Neo: - Age: Up-Down-Down |
PCLO | 1.711 | - | - | 0.755 | 0.956 | - | - | Mlig455_047806 {REF} {Length: 4640} {Pfam: C2 domain [PF00168.32, score=102.8]; PDZ domain [PF17820.3, score=23.7]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=117, Expect=4e-26]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [Score=83.2, Expect=4e-16]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=7e-15]} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=198, Expect=2e-52]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} Mlig455_047883 {REF} {Length: 3110} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=192, Expect=2e-55]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} |
83. | MligTC455_47949 | 48 | 1 | Mlig455_026482, Mlig455_026492 | Neo: - Age: - |
CHRNA3 | 1.709 | 0.744 | - | - | 0.965 | - | - | Mlig455_026482 {REF} {Length: 2240} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} Mlig455_026492 {REF} {Length: 1090} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} |
84. | MligTC455_48629 | 28 | 0.59 | Mlig455_025011 | Neo: - Age: - |
TRHR | 1.705 | - | - | - | 0.981 | - | 0.724 | Mlig455_025011 {REF} {Length: 3554} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=158.8]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=22.7]} {Human: ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [RH, Score=248, Expect=9e-78]} {Mouse: ENSMUSG00000038760, Trhr, thyrotropin releasing hormone receptor, [RH, Score=248, Expect=3e-78]} {Dmel: FBgn0038874, ETHR, [Score=141, Expect=4e-37]} {Celegans: WBGene00016265, trhr-1, Thyrotropin-Releasing Hormone Receptor, [Score=218, Expect=5e-67]} {Smed: dd_Smed_v6_16834_0_1, dd_Smed_v6_16834_0_1, [Score=246, Expect=5e-78]} {RNA1310_37398} {RNA815_29942} |
85. | MligTC455_34815 | 30 | 0.63 | Mlig455_020979 | Neo: - Age: - |
1.697 | - | - | 0.724 | - | 0.973 | - | Mlig455_020979 {REF} {Length: 1394} {RNA1310_37266} | |
86. | MligTC455_17039 | 24 | 0.5 | Mlig455_025016 | Neo: - Age: - |
1.696 | 0.729 | - | - | 0.967 | - | - | Mlig455_025016 {REF} {Length: 2009} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.8]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [RH, Score=209, Expect=1e-63]} {RNA1310_42205} {RNA815_15017} | |
87. | MligTC455_19567 | 76 | 1.59 | Mlig455_017855, Mlig455_047877 | Neo: - Age: - Region-enriched R2: 7.793/0.00005 |
1.693 | - | - | 0.721 | 0.972 | - | - | Mlig455_017855 {REF} {Length: 1874} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.0]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=3e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} Mlig455_047877 {REF} {Length: 1820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.8]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=2e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} |
|
88. | MligTC455_52550 | 164 | 3.41 | Mlig455_002239 | Neo: - |
1.685 | - | - | 0.729 | 0.956 | - | - | Mlig455_002239 {REF} {Length: 3509} {Pfam: Innexin [PF00876.20, score=62.4]} {Smed: dd_Smed_v6_9861_0_1, dd_Smed_v6_9861_0_1, [Score=60.1, Expect=9e-10]} {RNA1509_36214} {RNA1310_17023} {RNA815_33132} | |
89. | MligTC455_16899 | 789 | 16.45 | Mlig455_054163, Mlig455_060701 | Neo: - Age: - |
1.684 | - | - | 0.721 | - | 0.963 | - | Mlig455_054163 {REF} {Length: 1573} {RNA1509_32433} {RNA1310_22335} {RNA815_10376} Mlig455_060701 {REF} {Length: 1510} {RNA1509_32433} {RNA1310_22335} {RNA815_10376} |
|
90. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 1.679 | - | - | 0.703 | 0.976 | - | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
91. | MligTC455_16907 | 87 | 1.82 | Mlig455_008705 | Neo: - Age: Down-Up-Down |
SLC17A8 | 1.674 | 0.719 | - | - | 0.955 | - | - | Mlig455_008705 {REF} {Length: 1949} {Pfam: Major Facilitator Superfamily [PF07690.18, score=37.9]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=19.6]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=213, Expect=1e-65]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=212, Expect=1e-64]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=208, Expect=6e-64]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=215, Expect=1e-67]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=211, Expect=1e-64]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=207, Expect=4e-63]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=196, Expect=1e-58]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=189, Expect=1e-56]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=234, Expect=3e-73]} {RNA1509_38152} {RNA1310_19607.1} {RNA815_14894} |
92. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 1.673 | - | - | 0.708 | 0.965 | - | - | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
93. | MligTC455_44072 | 85 | 1.77 | Mlig455_013727 | Neo: - Age: - |
1.673 | - | - | - | - | 0.961 | 0.712 | Mlig455_013727 {REF} {Length: 1142} {RNA1509_46059} {RNA1310_23934.1} {RNA815_9260.3} | |
94. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 1.662 | 0.704 | - | - | 0.958 | - | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
95. | MligTC455_37661 | 36 | 0.75 | Mlig455_006638 | Neo: - Age: - |
0.991 | - | - | - | - | 0.991 | - | Mlig455_006638 {REF} {Length: 1069} {RNA1509_59832} {RNA1310_44297} {RNA815_33826} | |
96. | MligTC455_39487 | 163 | 3.4 | Mlig455_016534 | Neo: - |
0.985 | - | - | 0.985 | - | - | - | Mlig455_016534 {REF} {Length: 2067} {TRANSSPLICED} {RNA1509_28528} {RNA1310_28586} {RNA815_21057} | |
97. | MligTC455_51288 | 32 | 0.66 | Mlig455_033307 | Neo: - Age: - |
NRG2 | 0.981 | - | - | - | 0.981 | - | - | Mlig455_033307 {REF} {Length: 1876} {TRANSSPLICED} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=62.6]; Immunoglobulin domain [PF13927.8, score=57.8]; Immunoglobulin domain [PF00047.27, score=52.9]; Immunoglobulin domain [PF13895.8, score=42.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=21.9]; Immunoglobulin V-set domain [PF07686.19, score=21.5]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=78.6, Expect=9e-15]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [Score=79.3, Expect=5e-15]} {Dmel: FBgn0003984, vn, vein, [RH, Score=79.3, Expect=3e-15]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=58.5, Expect=1e-08]} {Smed: dd_Smed_v6_16809_0_1, dd_Smed_v6_16809_0_1, [RH, Score=77.8, Expect=3e-15]} {RNA1310_26045.2} {RNA815_30218} |
98. | MligTC455_41205 | 44 | 0.91 | Mlig455_002062 | Neo: - Age: - |
B4GALT2 | 0.979 | - | - | 0.979 | - | - | - | Mlig455_002062 {REF} {Length: 2766} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=126.5]; N-terminal domain of galactosyltransferase [PF02709.16, score=92.4]} {Human: ENSG00000117411, B4GALT2, beta-1,4-galactosyltransferase 2, [Score=218, Expect=3e-66]; ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=212, Expect=8e-64]; ENSG00000121578, B4GALT4, beta-1,4-galactosyltransferase 4, [Score=211, Expect=5e-64]; ENSG00000158470, B4GALT5, beta-1,4-galactosyltransferase 5, [Score=209, Expect=1e-62]; ENSG00000118276, B4GALT6, beta-1,4-galactosyltransferase 6, [Score=208, Expect=2e-62]} {Mouse: ENSMUSG00000028541, B4galt2, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2, [Score=218, Expect=1e-66]; ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=218, Expect=6e-66]; ENSMUSG00000017929, B4galt5, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5, [Score=211, Expect=1e-63]; ENSMUSG00000056124, B4galt6, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6, [Score=209, Expect=7e-63]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=206, Expect=1e-61]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=221, Expect=1e-67]} {Smed: dd_Smed_v6_13813_0_1, dd_Smed_v6_13813_0_1, [RH, Score=242, Expect=7e-77]} {RNA1310_30379} {RNA815_40748} |
99. | MligTC455_05325 | 71 | 1.48 | Mlig455_053845 | Neo: - Age: - Region-enriched R2: 9.011/0.00001 |
PDE1C | 0.978 | - | - | 0.978 | - | - | - | Mlig455_053845 {REF} {Length: 3417} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.5]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=92.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=533, Expect=2e-177]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=539, Expect=5e-180]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=533, Expect=2e-175]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=477, Expect=2e-157]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=597, Expect=0.0]} {RNA1509_35042} {RNA1310_15340} {RNA815_34103} |
100. | MligTC455_05326 | 69 | 1.45 | Mlig455_064642 | Neo: - Age: Down-Up-Up Region-enriched R2: 8.953/0.00001 |
0.978 | - | - | 0.978 | - | - | - | Mlig455_064642 {REF} {Length: 1359} {NoTransDecoderORF} {RNA1509_35042} {RNA1310_28854} {RNA815_34103} |